Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-09-23
DOI
10.1093/jnci/djab194
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
- (2021) Evan W. Weber et al. SCIENCE
- Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
- (2021) Concetta Quintarelli et al. Journal for ImmunoTherapy of Cancer
- CAR T-cell product performance in haematological malignancies before and after marketing authorisation
- (2020) Magdi Elsallab et al. LANCET ONCOLOGY
- CAR T cells: continuation in a revolution of immunotherapy
- (2020) Anurag K Singh et al. LANCET ONCOLOGY
- Joint profiling of chromatin accessibility and CAR-T integration site analysis at population and single-cell levels
- (2020) Wenliang Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acute lymphoblastic leukaemia
- (2020) Florent Malard et al. LANCET
- Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients
- (2020) Orit Itzhaki et al. Journal for ImmunoTherapy of Cancer
- CD19-directed CAR T-cell therapy in B-cell NHL
- (2020) Marie José Kersten et al. CURRENT OPINION IN ONCOLOGY
- The Contribution of Epigenetics to Cancer Immunotherapy
- (2020) Lorea Villanueva et al. TRENDS IN IMMUNOLOGY
- Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy
- (2020) Theodore S Nowicki et al. Cancer Discovery
- Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies
- (2020) Kevin R. Parker et al. CELL
- CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies
- (2020) Valentín Ortíz-Maldonado et al. MOLECULAR THERAPY
- Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
- (2020) Qing Deng et al. NATURE MEDICINE
- CAR T-cell associated neurotoxicity: Mechanisms, clinicopathologic correlates, and future directions
- (2019) Bradley D Hunter et al. JNCI-Journal of the National Cancer Institute
- CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
- (2019) Christopher L. Nobles et al. JOURNAL OF CLINICAL INVESTIGATION
- Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells associate with clinical outcomes in NHL
- (2018) John Rossi et al. BLOOD
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia
- (2018) Elad Jacoby et al. AMERICAN JOURNAL OF HEMATOLOGY
- Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
- (2018) Joseph A. Fraietta et al. NATURE
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
- (2018) Michäel Duruisseaux et al. Lancet Respiratory Medicine
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical epigenetics: seizing opportunities for translation
- (2018) María Berdasco et al. NATURE REVIEWS GENETICS
- Identification of a tumor suppressor network in T-cell leukemia
- (2017) Stefan Nagel et al. LEUKEMIA & LYMPHOMA
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- SPAG6 regulates cell apoptosis through the TRAIL signal pathway in myelodysplastic syndromes
- (2017) Xinxin Li et al. ONCOLOGY REPORTS
- The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
- (2016) Hendrik G. Stunnenberg et al. CELL
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
- (2016) Sebastian Moran et al. LANCET ONCOLOGY
- Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies
- (2016) Nathan Singh et al. Science Translational Medicine
- Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences
- (2016) Sebastian Moran et al. Epigenomics
- The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
- (2016) Aleco D’Andrea et al. Oncotarget
- Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
- (2014) Y. Xu et al. BLOOD
- Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2
- (2014) Zhe Ji et al. JOURNAL OF IMMUNOLOGY
- Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation
- (2011) Giulio Donati et al. JOURNAL OF CELL SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started